JPMorgan Reiterates Overweight Rating on Mirati Therapeutics (MRTX)

Go back to JPMorgan Reiterates Overweight Rating on Mirati Therapeutics (MRTX)

Form 8-K Mirati Therapeutics, For: Dec 05

December 6, 2022 6:02 AM EST

false 0001576263 0001576263 2022-12-05 2022-12-05... More

Form 4 Mirati Therapeutics, For: Dec 02 Filed by: Christensen Jamie

December 5, 2022 5:01 PM EST

.FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color: green; background-color: white; font-size: 10px; font-family: Times, serif; } .FormNumText { font-size: 12px; font-weight: bold; font-family: arial, helvetica, sans-serif; } .FormAttention { font-size: 12px; font-weight: bold; font-family: helvetica; } .FormText { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left; } .FormTextR { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right; } .FormTextC { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center; } .FormEMText { font-size: 12px; font-style: italic; font-weight: normal;... More

Form 8-K Mirati Therapeutics, For: Dec 02

December 2, 2022 8:01 AM EST

false 0001576263 0001576263 2022-12-02 2022-12-02... More